Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2024-05-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-24-010814
- Form type
- SC 13G
- Filer
- ODRE 2005 SLU
- CIK
- CIK 1921938
- Filed
- Jun 11, 2024
- Reporting period
- May 10, 2024
- Description
- Schedule 13G beneficial ownership